BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15254731)

  • 1. Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes.
    Zancai P; Cariati R; Quaia M; Guidoboni M; Rizzo S; Boiocchi M; Dolcetti R
    Int J Oncol; 2004 Aug; 25(2):345-55. PubMed ID: 15254731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells.
    Murata T; Puri RK
    Cell Immunol; 1997 Jan; 175(1):33-40. PubMed ID: 9015186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
    Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
    J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of Jak/STAT proteins in Epstein-Barr virus-infected B-cell lines from patients with posttransplant lymphoproliferative disorder.
    Nepomuceno RR; Snow AL; Robert Beatty P; Krams SM; Martinez OM
    Transplantation; 2002 Aug; 74(3):396-402. PubMed ID: 12177620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-thrombin inhibits interleukin-6-induced Stat3 signaling and gp130 gene expression in primary cultures of human lung fibroblasts.
    Bhat GJ; Raghu G; Gunaje JJ; Idell S
    Biochem Biophys Res Commun; 1999 Mar; 256(3):626-30. PubMed ID: 10080949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.
    Kopantzev Y; Heller M; Swaminathan N; Rudikoff S
    Oncogene; 2002 Oct; 21(44):6791-800. PubMed ID: 12360405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone.
    von Laue S; Finidori J; Maamra M; Shen XY; Justice S; Dobson PR; Ross RJ
    J Endocrinol; 2000 May; 165(2):301-11. PubMed ID: 10810294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP; Hocke GM
    Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
    Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach.
    French JD; Tschumper RC; Jelinek DF
    Leukemia; 2002 Jun; 16(6):1189-96. PubMed ID: 12040452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.
    Dahmen H; Horsten U; Küster A; Jacques Y; Minvielle S; Kerr IM; Ciliberto G; Paonessa G; Heinrich PC; Müller-Newen G
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):695-702. PubMed ID: 9560294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids promote the proliferation and antagonize the retinoic acid-mediated growth suppression of Epstein-Barr virus-immortalized B lymphocytes.
    Quaia M; Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
    Blood; 2000 Jul; 96(2):711-8. PubMed ID: 10887139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
    Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.
    Syed V; Ulinski G; Mok SC; Ho SM
    J Natl Cancer Inst; 2002 Apr; 94(8):617-29. PubMed ID: 11959895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes.
    Pomponi F; Cariati R; Zancai P; De Paoli P; Rizzo S; Tedeschi RM; Pivetta B; De Vita S; Boiocchi M; Dolcetti R
    Blood; 1996 Oct; 88(8):3147-59. PubMed ID: 8874215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
    Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
    Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.